Page last updated: 2024-10-27

gliclazide and Glaucoma

gliclazide has been researched along with Glaucoma in 1 studies

Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.

Glaucoma: An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Taylor, RF1

Other Studies

1 other study available for gliclazide and Glaucoma

ArticleYear
New drugs in ophthalmology.
    Australian journal of ophthalmology, 1981, Volume: 9, Issue:3

    Topics: Acyclovir; Antiviral Agents; Epinephrine; Eye Diseases; Glaucoma; Gliclazide; Humans; Hyaluronic Aci

1981